Comparison of efficacy and safety of oral corticosteriod mini pulse versus oral tofacitinib in stabilization and repigmentation of active vitiligo: A Randomized Controlled Trial

Research Cell, AIIMS Jodhpur0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年4月29日

试验速览

暂无简介。

•All consecutive patients with body weight >35 kg and age < 50 years, of either gender who are willing to participate and fulfill the following eligibility criteria for active vitiligo:
•1.Subjects with non-segmental, unstable vitiligo with body surface area involved >2%
•2.Disease activity in the past 3 months –
•a.New lesions
•b.Increase in the size of the older lesions
•c.Depigmentation of previously repigmented lesions

•Patient having any of the following criteria will be excluded from the study.
•1.Segmental vitiligo
•2.Pregnancy or lactation
•3.Presence of any of the following: immunocompromised host, malignancy, co-morbidities like uncontrolled diabetes, renal disease, hepatitis.
•4.Any known contraindication or hypersensitivity to any of the study molecules.

发起方

Research Cell, AIIMS Jodhpur